Selected summary of Bohne F, Martínez-Llordella M, Lozano JJ, et al. Intragraft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012;122: 368–382. Lifetime immunosuppressive therapy, which is usually needed to prevent rejection of the graft in solid organ transplantation, may have serious side effects resulting in increased morbidity and mortality. The liver is unique in organ transplantation; up to 20% of transplant recipients can be weaned off immunosuppressive drugs and display “operational tolerance” of the graft in the absence of immunosuppression (Transplantation 2011;91:1065–1974)..
There is still little understanding of the immune events that occur in transplant patients as they d...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
There is still little understanding of the immune events that occur in transplant patients as they d...
Selected summary of <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248302/"><i>Bohne F, Mart...
Contains fulltext : 108418.pdf (publisher's version ) (Open Access)Following organ...
In the past 40 years, liver transplantation has evolved from a high-risk procedure to one that offer...
In the past 40 years, liver transplantation has evolved from a high-risk procedure to one that offer...
In the past 40 years, liver transplantation has evolved from a high-risk procedure to one that offer...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
Minimization or withdrawal of immunosuppressive treatments after organ transplantation represents a ...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
BACKGROUND/AIMS: Hepatic iron may act as an important co-morbid factor in non-hemochromatotic liver ...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
There is still little understanding of the immune events that occur in transplant patients as they d...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
There is still little understanding of the immune events that occur in transplant patients as they d...
Selected summary of <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248302/"><i>Bohne F, Mart...
Contains fulltext : 108418.pdf (publisher's version ) (Open Access)Following organ...
In the past 40 years, liver transplantation has evolved from a high-risk procedure to one that offer...
In the past 40 years, liver transplantation has evolved from a high-risk procedure to one that offer...
In the past 40 years, liver transplantation has evolved from a high-risk procedure to one that offer...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
Minimization or withdrawal of immunosuppressive treatments after organ transplantation represents a ...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
BACKGROUND/AIMS: Hepatic iron may act as an important co-morbid factor in non-hemochromatotic liver ...
Life-long immunosuppression has always been considered the key in managing liver graft protection fr...
There is still little understanding of the immune events that occur in transplant patients as they d...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
There is still little understanding of the immune events that occur in transplant patients as they d...